Phellamurin
CAS No. 52589-11-4
Phellamurin( —— )
Catalog No. M29333 CAS No. 52589-11-4
Phellamurin inhibits intestinal P-glycoprotein in a dose-dependent manner, there is a serious interaction occurred between Phellamurin with cyclosporin, to ensure the efficacy of cyclosporin, we suggest that the coadministration of Phellamurin or Phellodendron wilsonii with cyclosporin should be avoided.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 303 | Get Quote |
|
| 10MG | 447 | Get Quote |
|
| 25MG | 714 | Get Quote |
|
| 50MG | 1017 | Get Quote |
|
| 100MG | 1368 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePhellamurin
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhellamurin inhibits intestinal P-glycoprotein in a dose-dependent manner, there is a serious interaction occurred between Phellamurin with cyclosporin, to ensure the efficacy of cyclosporin, we suggest that the coadministration of Phellamurin or Phellodendron wilsonii with cyclosporin should be avoided.
-
DescriptionPhellamurin inhibits intestinal P-glycoprotein in a dose-dependent manner, there is a serious interaction occurred between Phellamurin with cyclosporin, to ensure the efficacy of cyclosporin, we suggest that the coadministration of Phellamurin or Phellodendron wilsonii with cyclosporin should be avoided.(In Vitro):Administration of 0-10?μg/mL Phellamurin for 48 hours in U2OS and Saos-2?cells leads to a repression of cell viability dose-dependently, promotes the apoptosis of U2OS and Saos-2?cells concentration-dependently, and declines the ratios of p-PI3K/PI3K, p-AKT/AKT, and p-mTOR/mTOR in U2OS and Saos-2?cells.(In Vivo):Intraperitoneal injection of 50?mg/kg/day Phellamurin daily for 21 days in female BALB/c nude mice represses osteosarcoma tumor growth in vivo. The ratios of p-PI3K/PI3K, p-AKT/AKT, and p-mTOR/mTOR are decreased in xenograft in Phellamurin-treated mice.
-
In VitroPhellamurin (0-10?μg/mL; 48 hours; U2OS and Saos-2?cells) treatment leads to a repression of cell viability in U2OS and Saos-2?cells in a dose-dependent manner.Phellamurin (0-10?μg/mL; 48 hours; U2OS and Saos-2?cells) treatment concentration-dependently promots the apoptosis of U2OS and Saos-2?cells.Phellamurin (0-10?μg/mL; 48 hours; U2OS and Saos-2?cells) treatment declines the ratios of p-PI3K/PI3K, p-AKT/AKT, and p-mTOR/mTOR in U2OS and Saos-2?cells. Cell Viability Assay Cell Line:U2OS and Saos-2?cells Concentration:0 μg/mL, 2.5 μg/mL, 5 μg/mL, and 10?μg/mL Incubation Time:48 hours Result:Suppressed the viability of U2OS and Saos-2?cells in a concentration-dependent manner.Apoptosis Analysis Cell Line:U2OS and Saos-2?cells Concentration:0 μg/mL, 2.5 μg/mL, 5 μg/mL, and 10?μg/mL Incubation Time:48 hours Result:Induced apoptosis of U2OS and Saos-2?cells in a concentration-dependent manner.Western Blot Analysis Cell Line:U2OS and Saos-2?cells Concentration:0 μg/mL and 10?μg/mL Incubation Time:48 hours Result:Repressed the PI3K/AKT/mTOR pathway in U2OS and Saos-2?cells.
-
In VivoPhellamurin (50?mg/kg/day; intraperitoneal injection; daily; for 21 days; female BALB/c nude mice) treatment represses osteosarcoma tumor growth in vivo. The ratios of p-PI3K/PI3K, p-AKT/AKT, and p-mTOR/mTOR are decreased in xenograft in Phellamurin-treated mice. Animal Model:Athymic female BALB/c nude mice (6 weeks old ) injected with U2OS cells Dosage:50?mg/kg/day Administration:Intraperitoneal injection; daily; for 21 days Result:Repressed osteosarcoma tumor growth in vivo.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetP-glycoprotein
-
RecptorP-gp
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number52589-11-4
-
Formula Weight518.51
-
Molecular FormulaC26H30O11
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)=CCc(c(O[C@@H]([C@H](C1=O)O)c(cc2)ccc2O)c1c(O)c1)c1O[C@@H]([C@@H]([C@H]1O)O)O[C@H](CO)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Laniquidar
An orally active, third-generation P-glycoprotein inhibitor that inhibits the drug efflux pump P-glycoprotein.
-
Tariquidar
A potent, specific P-gp inhibitor with Kd of 5.1 nM.
-
Phellamurin
Phellamurin inhibits intestinal P-glycoprotein in a dose-dependent manner, there is a serious interaction occurred between Phellamurin with cyclosporin, to ensure the efficacy of cyclosporin, we suggest that the coadministration of Phellamurin or Phellodendron wilsonii with cyclosporin should be avoided.
Cart
sales@molnova.com